<DOC>
	<DOCNO>NCT01008514</DOCNO>
	<brief_summary>RATIONALE : Internal radiation therapy use radioactive material place directly near tumor kill tumor cell . It may also cause less damage normal tissue . PURPOSE : This phase II trial study well partial-breast radiation therapy work treat woman early-stage breast cancer .</brief_summary>
	<brief_title>Partial-Breast Radiation Therapy Treating Women With Early-Stage Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - To examine efficacy MammoSite® Radiation Therapy System ( RTS ) deliver partial-breast irradiation woman early-stage breast cancer . Secondary - To assess toxicity associate MammoSite® RTS patient . - To evaluate cosmetic result breast brachytherapy MammoSite® RTS . - To correlate cosmetic result use chemotherapy , volume implant , distance implant skin . - To correlate local recurrence rate time surgery implant . OUTLINE : Patients undergo placement MammoSite® Radiation Therapy System ( RTS ) device cavity tumor remove either time surgery percutaneously ultrasound guidance surgery . Within 2-5 day device implant , patient undergo partial-breast irradiation deliver MammoSite® RTS twice daily 5 day . After completion study therapy , patient follow periodically 5 year .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm ductal carcinoma situ ( DCIS ) breast invasive breast adenocarcinoma Stage 0 , I , II ( T2 , N0 ; tumor size ≤ 3 cm ) disease Pathologic stag axilla preferred Clinical staging axilla allow patient ≥ 70 year age hormone receptorpositive tumor Unicentric tumor Microscopic multifocality allow long total tumor size ≤ 3 cm Must undergone lumpectomy definitive surgery Negative surgical margin , define tumor ink margin resection final surgery Reexcision obtain negative margin allow Must adequate skin space balloon surface surface skin lung ( ≥ 7 mm ) No multicentric carcinoma ( invasive DCIS ) one quadrant No clinically pathologically positive regional lymph nod No extensive intraductal component , define DCIS extend beyond primary invasive component normal breast parenchyma compose &gt; 25 % primary tumor Hormone receptor status specify PATIENT CHARACTERISTICS : Menopausal status specify Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No collagenvascular disease , include follow : Dermatomyositis Systemic lupus erythematosus Sclerodermamixed connective tissue disease PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>ductal breast carcinoma situ</keyword>
	<keyword>stage IA breast cancer</keyword>
	<keyword>stage IB breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
</DOC>